A risk-benefit analysis of vaccination

被引：9
|
作者：
Heininger, Ulrich [1 ]
机构：
[1] Univ Childrens Hosp Basel, Div Pediat Infect Dis, CH-4005 Basel, Switzerland
来源：
VACCINE | 2009年 / 27卷
关键词：
Vaccination; Risk-benefit; CONJUGATE VACCINE; EFFICACY TRIAL; IMMUNIZATION; RUBELLA; CHILDHOOD; PERTUSSIS; CHILDREN; INFANTS; MEASLES; EVENTS;
D O I：
10.1016/j.vaccine.2009.10.010
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Impressive success has been achieved worldwide with population based immunisation programmes against several serious infectious diseases. This success is being threatened: the incidence of previously frequent, potentially devastating diseases decreases as a consequence of successful immunisation programmes and attention of the public shifts towards true and alleged "side effects" of vaccines, This can lead to the dilemma of waning public confidence in the necessity, tolerability and safety of vaccinations. Therefore, continuous evaluation of risks and benefits of vaccines is required and results of these need to be communicated broadly to strengthen the confidence in immunisation programmes. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码：G9 / G12
页数：4
相关论文
共 50 条
  • [21] ADVICE AND CONSENT + RISK-BENEFIT ANALYSIS
    BONINE, JE
    [J]. ATLANTIC, 1979, 243 (05): : 31 - 31
  • [22] Basic aspects of risk-benefit analysis
    Beckmann, J
    [J]. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1999, 25 (01): : 89 - 95
  • [23] Quantitative risk-benefit analysis of natalizumab
    Thompson, J. P.
    Noyes, K.
    Dorsey, E. R.
    Schwid, S. R.
    Holloway, R. G.
    [J]. NEUROLOGY, 2008, 71 (05) : 357 - 364
  • [24] Prostate Biopsy: A Risk-Benefit Analysis
    Loeb, Stacy
    [J]. JOURNAL OF UROLOGY, 2010, 183 (03): : 852 - 853
  • [25] Risk-benefit analysis of fish consumption
    Leblanc, Jean-Charles
    Sirot, Veronique
    Volatier, Jean-Luc
    [J]. CAHIERS DE NUTRITION ET DE DIETETIQUE, 2009, 44 (04): : 182 - 188
  • [26] Risk-Benefit Analysis of Bariatric Surgery
    Ludwig, Kaja
    Schneider-Koriath, Sylke
    Bernhardt, Joern
    Huettl, Thomas P.
    [J]. VISZERALMEDIZIN, 2010, 26 (01): : 21 - 25
  • [27] NEW ANTIMALARIALS - A RISK-BENEFIT ANALYSIS
    NOSTEN, F
    PRICE, RN
    [J]. DRUG SAFETY, 1995, 12 (04) : 264 - 273
  • [28] Best Practices in Risk-Benefit Analysis
    Verhagen, H.
    Tijhuis, M.
    Gunnlaugsdottir, H.
    Kalogeras, N.
    Leino, O.
    Lutejin, J.
    Magnusson, S.
    Odekerken, G.
    Pohjola, M.
    Tuomisto, J.
    Ueland, O.
    White, B.
    Holm, F.
    [J]. ANNALS OF NUTRITION AND METABOLISM, 2011, 58 : 415 - 415
  • [29] A RISK-BENEFIT ANALYSIS FOR THE TREATMENT OF HYPERTENSION
    BULPITT, CJ
    [J]. POSTGRADUATE MEDICAL JOURNAL, 1993, 69 (816) : 764 - 774
  • [30] A Risk-Benefit Analysis Is Coffee healthy?
    Richling, Elke
    Habermeyer, Michael
    [J]. CHEMIE IN UNSERER ZEIT, 2014, 48 (01) : 12 - 20
12345